ACT-NOW Implementation Guide
0.5.0 - ci-build New Zealand flag

ACT-NOW Implementation Guide, published by Te aho o te kahu - Cancer Control Agency. This guide is not an authorized publication; it is the continuous build for version 0.5.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/davidhay25/actnow/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 Api Input
... 3 Api Query
... 4 Architecture
... 5 Examples
... 6 Extensions
... 7 Profiles
... 8 Reference Implementation
... 9 Resource Graph
... 10 Terminology
... 11 Artifacts Summary
.... 11.1 CapabilityStatement representing the server requirements for a FHIR server
.... 11.2 an-supporting-info
.... 11.3 ACT-NOW diagnosis
.... 11.4 ACT-NOW medication administration
.... 11.5 ACT-NOW medication request
.... 11.6 ACT-NOW patient
.... 11.7 Body Surface Area
.... 11.8 Clinical M-score
.... 11.9 Clinical N-score
.... 11.10 Clinical T-score
.... 11.11 Clinical TNM group score
.... 11.12 Creatinine Clearance
.... 11.13 Cycle Careplan
.... 11.14 ECOG score
.... 11.15 Estrogen Receptor status
.... 11.16 Gleason score
.... 11.17 Height
.... 11.18 HER2 status
.... 11.19 Histology
.... 11.20 Pathological M-score
.... 11.21 Pathological N-score
.... 11.22 Pathological T-score
.... 11.23 Pathological TNM group score
.... 11.24 PR status
.... 11.25 Regimen Careplan
.... 11.26 Weight
.... 11.27 ClinicalTrial
.... 11.28 CourseNumber
.... 11.29 CycleCount
.... 11.30 CycleDay
.... 11.31 CycleNumber
.... 11.32 CyclePlannedLength
.... 11.33 DoseAdjustmentReason
.... 11.34 FacilityAdministered
.... 11.35 IOT
.... 11.36 LastAdminDate
.... 11.37 PrescribedDose
.... 11.38 RecurrenceType
.... 11.39 Regimen type
.... 11.40 RegimenDiscontinued
.... 11.41 RegimenOTU
.... 11.42 Basis of diagnosis
.... 11.43 Clinical M score
.... 11.44 Clinical N score
.... 11.45 Clinical T score
.... 11.46 Clinical TNM group
.... 11.47 Dose adjustment reason
.... 11.48 ECOG status
.... 11.49 ER status
.... 11.50 HER2 status
.... 11.51 Histology
.... 11.52 Intent of treatment
.... 11.53 Is on a clinical trial
.... 11.54 Outcome of a regimen
.... 11.55 Pathological M score
.... 11.56 Pathological N score
.... 11.57 Pathological T score
.... 11.58 Pathological TNM group
.... 11.59 Patient factors when discontinuing a regimen
.... 11.60 PR status
.... 11.61 The reason why a regimen was discontinued
.... 11.62 Toxicity reasons why a regimen was discontinued
.... 11.63 Type of recurrence
.... 11.64 bsa
.... 11.65 careplan-regimen-1
.... 11.66 careplan-regimen-2
.... 11.67 Clincial M value
.... 11.68 Clincial N value
.... 11.69 Clinical T value
.... 11.70 Clinical TNM group
.... 11.71 CreatinineClearance
.... 11.72 Cycle 1
.... 11.73 ERStatus
.... 11.74 Example practitioner
.... 11.75 ExObservationECOG
.... 11.76 ExObservationGleason
.... 11.77 ExObservationHeight
.... 11.78 ExObservationNoValueSystemWeight
.... 11.79 ExObservationWeight
.... 11.80 HER2Status
.... 11.81 Histology: Small cell lung cancer
.... 11.82 Lorrie Lung
.... 11.83 medicationadministration-1
.... 11.84 medicationrequest-1
.... 11.85 Pathological M value
.... 11.86 Pathological N value
.... 11.87 Pathological T value
.... 11.88 Pathological TNM group
.... 11.89 PRStatus
.... 11.90 Small cell lung cancer diagnosis